STOCK TITAN

Derek Maetzold reports multiple Rule 144 sales — CSTL (CSTL)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Derek Maetzold reported proposed sales of Common shares of CSTL under Rule 144, listing multiple transactions dated between 01/05/2026 and 03/18/2026.

The filing lists numerous individual dispositions by Mr. Maetzold and related trusts, with transaction entries showing share counts and dollar values for each trade, including a 23,179-share entry on 03/12/2026. The filing is a disclosure of proposed/resale transactions under Rule 144.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 resale disclosures list many small-to-mid sized sales by a single reporting family.

The filing catalogs numerous share dispositions by Derek Maetzold and affiliated trusts across January–March 2026, each row showing share counts and proceeds. These entries are standard Rule 144 resale notices that document intended or proposed sales rather than company actions.

Timing and cash‑flow treatment are set by the reported trade dates and proceeds lines; subsequent filings or broker confirmations would show settlement details.

Multiple dated sale entries imply ongoing dispositions rather than a single block sale.

Entries include repeated trades of 1,339 shares on several January 2026 dates and larger entries such as 23,179 shares on 03/12/2026. The table-style listing is consistent with routine sell-through of previously acquired or issued shares.

Impact on free float depends on total outstanding shares, which are not provided in the excerpt; market impact cannot be assessed from these rows alone.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What transactions does the CSTL Form 144 by Derek Maetzold show?

The Form 144 lists multiple proposed sales of Common shares dated between 01/05/2026 and 03/18/2026. Each line shows the selling party, trade date, number of shares, and the gross dollar amount for that disposition.

How many shares were in the largest sale reported in the filing?

The largest single entry shown is 23,179 shares reported on 03/12/2026. The filing presents this as a listed disposition line with an associated gross dollar figure; it does not aggregate totals across entries.

Who are the selling parties listed in the CSTL filing?

Selling parties include Derek Maetzold individually and several related trusts (for example, the Maetzold 2018 Remainder Trust and Derek Maetzold 2020 Irrevocable Trust). Each party appears with discrete share-sale entries and dollar amounts.

Do the Form 144 entries state proceeds treatment or buyer identity?

Each row shows a gross dollar amount for the trade, but the excerpt does not specify buyer identities or whether proceeds go to the issuer or selling holders. The lines reflect reported sale proceeds per trade date as displayed.

Are these filings evidence of new insider compensation or option exercises?

The listed dispositions are resale/sale entries. The excerpt includes prior acquisition notes (e.g., "Acquired as gift" and "Compensation -- Stock Options" acquisition dates) but the current Form 144 rows record sales, not new grants or exercises.
Castle Biosciences

NASDAQ:CSTL

View CSTL Stock Overview

CSTL Rankings

CSTL Latest News

CSTL Latest SEC Filings

CSTL Stock Data

734.36M
28.39M
Diagnostics & Research
Services-medical Laboratories
Link
United States
FRIENDSWOOD